Preface
Contributors
- Epidemiology, Staging and Clinical Characteristics
Christina S. Chu & Stephen C. Rubin - Preoperative Preparation and Surgical Instrumentation
Michael A. Bidus, G. Scott Rose, John C. Elkas - Management of Early-Stage Ovarian Cancer
Anil K. Sood, Koji Matsuo & David M. Gershenson - Cytoreductive Surgery: Principles and Rationale
Christine H. Holschneider & Beth Y. Karlan - Cytoreductive Surgery: Pelvis
Robert E. Bristow & Leo D. Lagasse - Cytoreductive Surgery: Abdominal Retroperitoneum and Adenopathy
Jason D. Wright, Thomas J. Herzog, and Nadeem R. Abu-Rustum - Cytoreductive Surgery: Intestinal Tract and Omentum
Yukio Sonoda, Dennis S. Chi, and Richard R. Barakat - Cytoreductive Surgery Right Upper Abdomen
Robert L. Giuntoli, II, Richard D. Schulick, Robert E. Bristow, and William A. Cliby - Cytoreductive Surgery: Upper Abdomen - Left Hypochondriac and Epigastric Regions
Alejandra Martinez, Krishnansu S. Tewari, Gwénael Ferron & Pedro T. Ramirez - Surgical Issues for Intraperitoneal Chemotherapy
Lisa M. Landrum and Joan L. Walker - Secondary Cytoreductive Surgery
Robert E. Bristow & Dennis S. Chi - Minimally Invasive Surgery
Ritu Salani, David E. Cohn & Jeffrey M. Fowler - Palliative Surgery for Ovarian Cancer
Laura J. Havrilesky, Alberto Mendivil and Daniel L. Clarke-Pearson - Postoperative Management
Lee-May Chen - Advanced Cytoreductive Surgery Program Development: Building a Cytoreductive Team
Oliver Zivanovic, Dennis S. Chia & Beth Y. Karlan
Index
Robert E. Bristow, MD, MBA, is Professor and Director of the Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, University of California, Irvine – Medical Center in Orange, California, USA. Professor Bristow’s primary clinical and research interests include the surgical management of advanced-stage gynecologic cancer and the patterns of health care delivery for women with gynecologic cancer. Dr. Bristow is extensively published in the field of ovarian cancer surgical research and he is also a deputy editor of the journal Gynecologic Oncology.
Beth Y. Karlan, MD, is Director of the Women’s Cancer Research Institute and the Division of Gynecologic Oncology at Cedars-Sinai Medical Center and Professor of Obstetrics and Gynecology at the David Geffen School of Medicine at the University of California, Los Angeles, California, USA. Professor Karlan’s research interests include molecular biomarker discovery, inherited cancer susceptibility and translational research efforts focused towards innovative treatment strategies for ovarian cancer. She has served as President of the Society of Gynecologic Oncologists and in 2006 was named an American Cancer Society Early Detection Clinical Research Professor. Professor Karlan is the Editor-in-Chief of Gynecologic Oncology.
Dennis S. Chi, MD, is Professor and Deputy Chief of the Gynecology Service, Department of Surgery, Memorial Sloan-Kettering Cancer Center, New York, New York, USA. Dr Chi’s primary research interests include the correlation of radiographic evaluation and operative findings in gynecologic malignancies and the utilization of innovative and advanced surgical techniques to improve outcomes for women with early, advanced, or recurrent gynecologic cancers. He is on the editorial board of the journals Journal of Oncology and The Oncologist and has served as the president of the Society of Memorial Gynecologic Oncologists and the Metropolitan Gynecologic Cancer Society.

